Top compounds associated with response to CT62

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	Gefitinib	GDSC1000	pan-cancer	AAC	-0.017	0.6
mRNA	PIK-93	CTRPv2	pan-cancer	AAC	-0.018	0.6
mRNA	istradefylline	CTRPv2	pan-cancer	AAC	-0.029	0.6
mRNA	alisertib:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.018	0.6
mRNA	BIBW2992	FIMM	pan-cancer	AAC	-0.081	0.6
mRNA	clofarabine	CTRPv2	pan-cancer	AAC	-0.015	0.6
mRNA	YM-155	GDSC1000	pan-cancer	AAC	0.017	0.6
mRNA	tivozanib	CTRPv2	pan-cancer	AAC	-0.019	0.6
mRNA	piperlongumine:MST-312 (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.018	0.6
mRNA	ruxolitinib	CTRPv2	pan-cancer	AAC	-0.018	0.6

Download CSV